Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors
Identifieur interne : 001884 ( Istex/Corpus ); précédent : 001883; suivant : 001885Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors
Auteurs : Timothy L. Lash ; Rebecca A. SillimanSource :
- The Breast Journal [ 1075-122X ] ; 2002-01.
Abstract
We enrolled a cohort of 303 stage I or stage II breast cancer patients diagnosed in Boston, MA, between October 1992 and December 1995. We followed the patients by interview and medical record abstract for 5 years (a) to characterize the incidence and predictors of upper‐body function decline and (b) to characterize the incidence and predictors of recovery of upper‐body function. The incidence of decline in the first year after therapy (17.7/100 person years) was substantially higher than in the subsequent 4 years of follow‐up (11.0/100 person‐years, p value for test of homogeneity equal 0.028). With only one exception, no patient characteristic, therapy component, or disease trait was associated with decline over the full follow‐up period. Women with less than a high school education had an adjusted relative hazard of decline of 2.3 (95% CI, 1.4–3.7) compared with women with a high school education or more, possibly reflecting occupational or environmental insults that predispose to functional impairment. Women who had reported a decline in upper‐body function and who subsequently saw their breast cancer specialist were 4.8‐fold more likely to report that they had recovered their upper‐body function at their next interview (95% CI, 2.0, 12). This finding suggests that attention to upper‐body function during follow‐up visits may facilitate recovery.
Url:
DOI: 10.1046/j.1524-4741.2002.08006.x
Links to Exploration step
ISTEX:35D19569135956580C3BA0811E71406B1843D388Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors</title><author><name sortKey="Lash, Timothy L" sort="Lash, Timothy L" uniqKey="Lash T" first="Timothy L." last="Lash">Timothy L. Lash</name><affiliation><mods:affiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, Geriatrics Section, Boston Medical Center,</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, and</mods:affiliation></affiliation></author><author><name sortKey="Silliman, Rebecca A" sort="Silliman, Rebecca A" uniqKey="Silliman R" first="Rebecca A." last="Silliman">Rebecca A. Silliman</name><affiliation><mods:affiliation>Department of Medicine, Boston University School of Medicine, Geriatrics Section, Boston Medical Center, Boston, Massachusetts</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:35D19569135956580C3BA0811E71406B1843D388</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1046/j.1524-4741.2002.08006.x</idno><idno type="url">https://api.istex.fr/document/35D19569135956580C3BA0811E71406B1843D388/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001884</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001884</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors</title><author><name sortKey="Lash, Timothy L" sort="Lash, Timothy L" uniqKey="Lash T" first="Timothy L." last="Lash">Timothy L. Lash</name><affiliation><mods:affiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, Geriatrics Section, Boston Medical Center,</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, and</mods:affiliation></affiliation></author><author><name sortKey="Silliman, Rebecca A" sort="Silliman, Rebecca A" uniqKey="Silliman R" first="Rebecca A." last="Silliman">Rebecca A. Silliman</name><affiliation><mods:affiliation>Department of Medicine, Boston University School of Medicine, Geriatrics Section, Boston Medical Center, Boston, Massachusetts</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">The Breast Journal</title><title level="j" type="alt">BREAST JOURNAL</title><idno type="ISSN">1075-122X</idno><idno type="eISSN">1524-4741</idno><imprint><biblScope unit="vol">8</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="28">28</biblScope><biblScope unit="page" to="33">33</biblScope><biblScope unit="page-count">6</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Boston, MA, USA</pubPlace><date type="published" when="2002-01">2002-01</date></imprint><idno type="ISSN">1075-122X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1075-122X</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We enrolled a cohort of 303 stage I or stage II breast cancer patients diagnosed in Boston, MA, between October 1992 and December 1995. We followed the patients by interview and medical record abstract for 5 years (a) to characterize the incidence and predictors of upper‐body function decline and (b) to characterize the incidence and predictors of recovery of upper‐body function. The incidence of decline in the first year after therapy (17.7/100 person years) was substantially higher than in the subsequent 4 years of follow‐up (11.0/100 person‐years, p value for test of homogeneity equal 0.028). With only one exception, no patient characteristic, therapy component, or disease trait was associated with decline over the full follow‐up period. Women with less than a high school education had an adjusted relative hazard of decline of 2.3 (95% CI, 1.4–3.7) compared with women with a high school education or more, possibly reflecting occupational or environmental insults that predispose to functional impairment. Women who had reported a decline in upper‐body function and who subsequently saw their breast cancer specialist were 4.8‐fold more likely to report that they had recovered their upper‐body function at their next interview (95% CI, 2.0, 12). This finding suggests that attention to upper‐body function during follow‐up visits may facilitate recovery.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>breast cancer</json:string><json:string>axillary</json:string><json:string>function decline</json:string><json:string>independent variables</json:string><json:string>predictor</json:string><json:string>silliman</json:string><json:string>person years</json:string><json:string>breast cancer therapy</json:string><json:string>breast cancer survivors</json:string><json:string>breast cancer patients</json:string><json:string>high school education</json:string><json:string>incidence rate</json:string><json:string>axillary dissection</json:string><json:string>relative hazard</json:string><json:string>person time</json:string><json:string>breast cancer specialists</json:string><json:string>hormonal therapy</json:string><json:string>national cancer institute</json:string><json:string>high school</json:string><json:string>dependent variables</json:string><json:string>survivor</json:string><json:string>breast cancer stage</json:string><json:string>natl cancer inst</json:string><json:string>coexisting conditions</json:string><json:string>public health</json:string><json:string>radiation therapy</json:string><json:string>radiation oncologist</json:string><json:string>medical oncologist</json:string><json:string>boston university school</json:string><json:string>breast</json:string><json:string>pacific islander education</json:string><json:string>measure function</json:string><json:string>marital status</json:string><json:string>demographic variables</json:string><json:string>telephone interviews</json:string><json:string>medical intervention</json:string><json:string>breast cancer surgeon</json:string><json:string>medical records</json:string><json:string>older women</json:string><json:string>therapy characteristics</json:string><json:string>breast neoplasms</json:string><json:string>next interview</json:string><json:string>proportional hazards models</json:string><json:string>predictive models</json:string><json:string>breast cancer specialist</json:string><json:string>overall incidence rate</json:string><json:string>crude effect</json:string><json:string>education level</json:string><json:string>years ethnicity caucasian african american hispanic asian</json:string><json:string>health survey</json:string><json:string>high school employment</json:string><json:string>relationship status</json:string><json:string>someone body mass index</json:string><json:string>therapy person years</json:string><json:string>cardiopulmonary comorbidity score</json:string><json:string>more arthritis</json:string><json:string>primary therapy group</json:string><json:string>mastectomy chemotherapy</json:string><json:string>axillary node dissection</json:string><json:string>likelihood test</json:string><json:string>proportional hazards model</json:string><json:string>physical exam</json:string><json:string>upper body function</json:string><json:string>first year</json:string><json:string>national institutes</json:string><json:string>geriatrics section</json:string><json:string>hand function</json:string><json:string>radical mastectomy</json:string><json:string>early stage breast cancer</json:string></teeft></keywords><author><json:item><name>Timothy L. Lash DSc, MPH</name><affiliations><json:string>Department of Epidemiology and Biostatistics, Boston University School of Public Health, Geriatrics Section, Boston Medical Center,</json:string><json:string>Department of Epidemiology and Biostatistics, Boston University School of Public Health, and</json:string></affiliations></json:item><json:item><name>Rebecca A. Silliman MD, PhD</name><affiliations><json:string>Department of Medicine, Boston University School of Medicine, Geriatrics Section, Boston Medical Center, Boston, Massachusetts</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>breast neoplasms</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>complications</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>breast neoplasms</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>therapy</value></json:item></subject><articleId><json:string>tbj08006</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>We enrolled a cohort of 303 stage I or stage II breast cancer patients diagnosed in Boston, MA, between October 1992 and December 1995. We followed the patients by interview and medical record abstract for 5 years (a) to characterize the incidence and predictors of upper‐body function decline and (b) to characterize the incidence and predictors of recovery of upper‐body function. The incidence of decline in the first year after therapy (17.7/100 person years) was substantially higher than in the subsequent 4 years of follow‐up (11.0/100 person‐years, p value for test of homogeneity equal 0.028). With only one exception, no patient characteristic, therapy component, or disease trait was associated with decline over the full follow‐up period. Women with less than a high school education had an adjusted relative hazard of decline of 2.3 (95% CI, 1.4–3.7) compared with women with a high school education or more, possibly reflecting occupational or environmental insults that predispose to functional impairment. Women who had reported a decline in upper‐body function and who subsequently saw their breast cancer specialist were 4.8‐fold more likely to report that they had recovered their upper‐body function at their next interview (95% CI, 2.0, 12). This finding suggests that attention to upper‐body function during follow‐up visits may facilitate recovery.</abstract><qualityIndicators><score>5.895</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 783 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1371</abstractCharCount><pdfWordCount>3387</pdfWordCount><pdfCharCount>21886</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>209</abstractWordCount></qualityIndicators><title>Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors</title><genre><json:string>article</json:string></genre><host><title>The Breast Journal</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1524-4741</json:string></doi><issn><json:string>1075-122X</json:string></issn><eissn><json:string>1524-4741</json:string></eissn><publisherId><json:string>TBJ</json:string></publisherId><volume>8</volume><issue>1</issue><pages><first>28</first><last>33</last><total>6</total></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>science</json:string><json:string>oncology</json:string><json:string>obstetrics & gynecology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>oncology & carcinogenesis</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string></inist></categories><publicationDate>2002</publicationDate><copyrightDate>2002</copyrightDate><doi><json:string>10.1046/j.1524-4741.2002.08006.x</json:string></doi><id>35D19569135956580C3BA0811E71406B1843D388</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/35D19569135956580C3BA0811E71406B1843D388/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/35D19569135956580C3BA0811E71406B1843D388/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/35D19569135956580C3BA0811E71406B1843D388/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors</title></titleStmt><publicationStmt><publisher>Blackwell Science Inc</publisher><pubPlace>Boston, MA, USA</pubPlace><date type="published" when="2002-01"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors</title><title level="a" type="short">Upper‐Body Function in Breast Cancer Survivors</title><author xml:id="author-0000"><persName><forename type="first">Timothy L.</forename><surname>Lash</surname><roleName type="degree">DSc, MPH</roleName></persName><affiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, Geriatrics Section, Boston Medical Center,</affiliation><affiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, and</affiliation></author><author xml:id="author-0001"><persName><forename type="first">Rebecca A.</forename><surname>Silliman</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Medicine, Boston University School of Medicine, Geriatrics Section, Boston Medical Center, Boston, Massachusetts<address><country key="US"></country></address></affiliation></author><idno type="istex">35D19569135956580C3BA0811E71406B1843D388</idno><idno type="DOI">10.1046/j.1524-4741.2002.08006.x</idno><idno type="supplier">tbj08006</idno><idno type="unit">TBJ8006</idno><idno type="toTypesetVersion">file:TBJ.TBJ8006.pdf</idno></analytic><monogr><title level="j" type="main">The Breast Journal</title><title level="j" type="alt">BREAST JOURNAL</title><idno type="pISSN">1075-122X</idno><idno type="eISSN">1524-4741</idno><idno type="book-DOI">10.1111/(ISSN)1524-4741</idno><idno type="book-part-DOI">10.1111/tbj.2002.8.issue-1</idno><idno type="product">TBJ</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">8</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="28">28</biblScope><biblScope unit="page" to="33">33</biblScope><biblScope unit="page-count">6</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Boston, MA, USA</pubPlace><date type="published" when="2002-01"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><abstract xml:lang="en" style="main"><p>We enrolled a cohort of 303 stage I or stage II breast cancer patients diagnosed in Boston, MA, between October 1992 and December 1995. We followed the patients by interview and medical record abstract for 5 years (a) to characterize the incidence and predictors of upper‐body function decline and (b) to characterize the incidence and predictors of recovery of upper‐body function. The incidence of decline in the first year after therapy (17.7/100 person years) was substantially higher than in the subsequent 4 years of follow‐up (11.0/100 person‐years, <hi rend="italic">p</hi> value for test of homogeneity equal 0.028). With only one exception, no patient characteristic, therapy component, or disease trait was associated with decline over the full follow‐up period. Women with less than a high school education had an adjusted relative hazard of decline of 2.3 (95% CI, 1.4–3.7) compared with women with a high school education or more, possibly reflecting occupational or environmental insults that predispose to functional impairment. Women who had reported a decline in upper‐body function and who subsequently saw their breast cancer specialist were 4.8‐fold more likely to report that they had recovered their upper‐body function at their next interview (95% CI, 2.0, 12). This finding suggests that attention to upper‐body function during follow‐up visits may facilitate recovery.</p></abstract><textClass><keywords xml:lang="en"><term xml:id="k1">breast neoplasms</term><term xml:id="k2">complications</term><term xml:id="k3">breast neoplasms</term><term xml:id="k4">therapy</term></keywords><classCode scheme="tocHeading1">Original Article</classCode></textClass><langUsage><language ident="EN"></language></langUsage></profileDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/35D19569135956580C3BA0811E71406B1843D388/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Science Inc</publisherName><publisherLoc>Boston, MA, USA</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1524-4741</doi><issn type="print">1075-122X</issn><issn type="electronic">1524-4741</issn><idGroup><id type="product" value="TBJ"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="BREAST JOURNAL">The Breast Journal</title><title type="short">The Breast Journal</title></titleGroup></publicationMeta><publicationMeta level="part" position="01001"><doi origin="wiley">10.1111/tbj.2002.8.issue-1</doi><numberingGroup><numbering type="journalVolume" number="8">8</numbering><numbering type="journalIssue" number="1">1</numbering></numberingGroup><coverDate startDate="2002-01">January/February 2002</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="0002800" status="forIssue"><doi origin="wiley">10.1046/j.1524-4741.2002.08006.x</doi><idGroup><id type="supplier" value="tbj08006"></id><id type="unit" value="TBJ8006"></id></idGroup><countGroup><count type="pageTotal" number="6"></count></countGroup><titleGroup><title type="tocHeading1">Original Article</title></titleGroup><eventGroup><event type="firstOnline" date="2002-04-30"></event><event type="publishedOnlineFinalForm" date="2002-04-30"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.4 mode:FullText source:FullText result:FullText" date="2010-03-30"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-10"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-04"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="28">28</numbering><numbering type="pageLast" number="33">33</numbering></numberingGroup><correspondenceTo>Address correspondence and reprint requests to: Timothy Lash, DSc, MPH, Boston University Medical Center, 88 East Newton Street, F433, Boston, MA 02118, U.S.A.</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:TBJ.TBJ8006.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="tableTotal" number="3"></count><count type="referenceTotal" number="26"></count><count type="wordTotal" number="3833"></count><count type="linksPubMed" number="19"></count><count type="linksCrossRef" number="2"></count></countGroup><titleGroup><title type="main">Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors</title><title type="shortAuthors">Lash et al.</title><title type="short">Upper‐Body Function in Breast Cancer Survivors</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1 #a2"><personName><givenNames>Timothy L.</givenNames><familyName>Lash</familyName><degrees>DSc, MPH</degrees></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a3"><personName><givenNames>Rebecca A.</givenNames><familyName>Silliman</familyName><degrees>MD, PhD</degrees></personName></creator></creators><affiliationGroup><affiliation xml:id="a1"><unparsedAffiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, Geriatrics Section, Boston Medical Center,</unparsedAffiliation></affiliation><affiliation xml:id="a2"><unparsedAffiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, and</unparsedAffiliation></affiliation><affiliation xml:id="a3" countryCode="US"><unparsedAffiliation>Department of Medicine, Boston University School of Medicine, Geriatrics Section, Boston Medical Center, Boston, Massachusetts</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">breast neoplasms</keyword><keyword xml:id="k2">complications</keyword><keyword xml:id="k3">breast neoplasms</keyword><keyword xml:id="k4">therapy</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p>We enrolled a cohort of 303 stage I or stage II breast cancer patients diagnosed in Boston, MA, between October 1992 and December 1995. We followed the patients by interview and medical record abstract for 5 years (a) to characterize the incidence and predictors of upper‐body function decline and (b) to characterize the incidence and predictors of recovery of upper‐body function. The incidence of decline in the first year after therapy (17.7/100 person years) was substantially higher than in the subsequent 4 years of follow‐up (11.0/100 person‐years, <i>p</i> value for test of homogeneity equal 0.028). With only one exception, no patient characteristic, therapy component, or disease trait was associated with decline over the full follow‐up period. Women with less than a high school education had an adjusted relative hazard of decline of 2.3 (95% CI, 1.4–3.7) compared with women with a high school education or more, possibly reflecting occupational or environmental insults that predispose to functional impairment. Women who had reported a decline in upper‐body function and who subsequently saw their breast cancer specialist were 4.8‐fold more likely to report that they had recovered their upper‐body function at their next interview (95% CI, 2.0, 12). This finding suggests that attention to upper‐body function during follow‐up visits may facilitate recovery.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Upper‐Body Function in Breast Cancer Survivors</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors</title></titleInfo><name type="personal"><namePart type="given">Timothy L.</namePart><namePart type="family">Lash</namePart><namePart type="termsOfAddress">DSc, MPH</namePart><affiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, Geriatrics Section, Boston Medical Center,</affiliation><affiliation>Department of Epidemiology and Biostatistics, Boston University School of Public Health, and</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Rebecca A.</namePart><namePart type="family">Silliman</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Medicine, Boston University School of Medicine, Geriatrics Section, Boston Medical Center, Boston, Massachusetts</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Science Inc</publisher><place><placeTerm type="text">Boston, MA, USA</placeTerm></place><dateIssued encoding="w3cdtf">2002-01</dateIssued><copyrightDate encoding="w3cdtf">2002</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">3</extent><extent unit="references">26</extent><extent unit="words">3833</extent></physicalDescription><abstract lang="en">We enrolled a cohort of 303 stage I or stage II breast cancer patients diagnosed in Boston, MA, between October 1992 and December 1995. We followed the patients by interview and medical record abstract for 5 years (a) to characterize the incidence and predictors of upper‐body function decline and (b) to characterize the incidence and predictors of recovery of upper‐body function. The incidence of decline in the first year after therapy (17.7/100 person years) was substantially higher than in the subsequent 4 years of follow‐up (11.0/100 person‐years, p value for test of homogeneity equal 0.028). With only one exception, no patient characteristic, therapy component, or disease trait was associated with decline over the full follow‐up period. Women with less than a high school education had an adjusted relative hazard of decline of 2.3 (95% CI, 1.4–3.7) compared with women with a high school education or more, possibly reflecting occupational or environmental insults that predispose to functional impairment. Women who had reported a decline in upper‐body function and who subsequently saw their breast cancer specialist were 4.8‐fold more likely to report that they had recovered their upper‐body function at their next interview (95% CI, 2.0, 12). This finding suggests that attention to upper‐body function during follow‐up visits may facilitate recovery.</abstract><subject lang="en"><genre>keywords</genre><topic>breast neoplasms</topic><topic>complications</topic><topic>breast neoplasms</topic><topic>therapy</topic></subject><relatedItem type="host"><titleInfo><title>The Breast Journal</title></titleInfo><titleInfo type="abbreviated"><title>The Breast Journal</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">1075-122X</identifier><identifier type="eISSN">1524-4741</identifier><identifier type="DOI">10.1111/(ISSN)1524-4741</identifier><identifier type="PublisherID">TBJ</identifier><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>28</start><end>33</end><total>6</total></extent></part></relatedItem><identifier type="istex">35D19569135956580C3BA0811E71406B1843D388</identifier><identifier type="DOI">10.1046/j.1524-4741.2002.08006.x</identifier><identifier type="ArticleID">tbj08006</identifier><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Science Inc</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001884 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001884 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:35D19569135956580C3BA0811E71406B1843D388
|texte= Long‐Term Follow‐Up of Upper‐Body Function Among Breast Cancer Survivors
}}
| This area was generated with Dilib version V0.6.31. |  |